National Health Investors, Inc. (NHI) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NHI Revenue Growth
Revenue Breakdown (FY 2025)
NHI's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
NHI Revenue Analysis (2014–2025)
As of May 6, 2026, National Health Investors, Inc. (NHI) generated trailing twelve-month (TTM) revenue of $402.2 million, reflecting exceptional growth of +28.9% year-over-year. The most recent quarter (Q1 2026) recorded $115.1 million in revenue, up 8.1% sequentially.
Looking at the longer-term picture, NHI's 5-year compound annual growth rate (CAGR) stands at +2.6%, indicating moderate growth over time. The company achieved its highest annual revenue of $378.5 million in 2025, representing a new all-time high.
Revenue diversification analysis shows NHI's business is primarily driven by Real Estate Investment Segment (79%), and Senior Housing Operating Portfolio (21%). With over half of revenue concentrated in Real Estate Investment Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Real Estate sector peers including OHI (+14.2% YoY), SBRA (+12.9% YoY), and LTC (+25.3% YoY), NHI has underperformed the peer group in terms of revenue growth. Compare NHI vs OHI →
NHI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NHICurrent | $402M | +28.9% | +2.6% | 51.5% | |
 OHI | $1.2B | +14.2% | +6.1% | 62.6% | |
 SBRA | $775M | +12.9% | +5.3% | 34.1% | |
 LTC | $263M | +25.3% | +10.5% | 79.4% | |
 CTRE | $476M | +47.6% | +22.1% | 98.7% | |
 GMRE | $138M | +8.5% | +14.4% | 23.6% |
NHI Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $378.5M | +12.9% | $138.9M | 36.7% | $194.8M | 51.5% |
| 2024 | $335.2M | +4.8% | $324.0M | 96.7% | $183.9M | 54.9% |
| 2023 | $319.8M | +15.0% | $308.3M | 96.4% | $178.8M | 55.9% |
| 2022 | $278.2M | -6.9% | $268.4M | 96.5% | $132.8M | 47.7% |
| 2021 | $298.7M | -10.2% | $287.1M | 96.1% | $185.3M | 62.0% |
| 2020 | $332.8M | +4.6% | $323.2M | 97.1% | $224.9M | 67.6% |
| 2019 | $318.1M | +8.0% | $312.3M | 98.2% | $220.0M | 69.2% |
| 2018 | $294.6M | +5.7% | $293.4M | 99.6% | $209.2M | 71.0% |
| 2017 | $278.7M | +12.1% | $277.7M | 99.7% | $197.8M | 71.0% |
| 2016 | $248.5M | +8.5% | $247.5M | 99.6% | $177.7M | 71.5% |
See NHI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NHI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NHI vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonNHI — Frequently Asked Questions
Quick answers to the most common questions about buying NHI stock.
Is NHI's revenue growth accelerating or slowing?
NHI revenue is accelerating at +28.9% year-over-year, exceeding the 5-year CAGR of +2.6%. TTM revenue reached $402M. Growth momentum has increased versus prior periods.
What is NHI's long-term revenue growth rate?
National Health Investors, Inc.'s 5-year revenue CAGR of +2.6% reflects the sustained expansion pattern. Current YoY growth of +28.9% is above this long-term average.
How is NHI's revenue distributed by segment?
NHI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.